Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Biotech Dental and Henry Schein Join to Improve Patient Outcomes

Biotech Dental and Henry Schein Join to Improve Patient Outcomes

19th December 2022

The shareholders of Biotech Dental S.A.S. and Henry Schein have publicised a deal for Henry Schein to purchase a controlling share in the business.
Chief Executive Officer of Henry Schein, Stanley M. Bergman, expressed that “Henry Schein and Biotech Dental are committed to offering customers best-in-class, user-friendly, customer-centric solutions based on open architecture that help improve patient outcomes.”
The collaboration will enable Biotech Dental to expand its product reach to additional dental practises, dental labs, and regions. This contract’s closure is dependent on receiving specific legal clearances.
Bergman continued to say that “Henry Schein will, over time, incorporate Biotech’s Nemotec software as part of our solutions offering, including integrating Biotech’s software solutions with Henry Schein One’s industry-leading practice management software solutions to create a leading end-to-end clinical system and to help dental practitioners streamline their clinical as well as administrative workflow.”
Although he also said that Biotech Dental will continue to use its own branding and marketing approaches: “We are committed to maintaining the French operations of Biotech, which will become centers of excellence for some of our combined processes and manufacturing operations.”
Founder of Biotech Dental, Philippe Veran, explained that they will “continue to manufacture products in France while bringing innovation and new technologies to the global dental community. Together, with Henry Schein, we look forward to helping our customers enhance their surgical skills, achieve better outcomes for their patients, and maximize business success.”
In accordance with the terms of the deal, Henry Schein will purchase a controlling interest in Biotech Dental, with outstanding shares staying under the ownership of Upperside Capital Partners Group.
© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.